Company profile: Overwatch Research
1.1 - Company Overview
Company description
- Provider of all-in-one experimental tracking software for in vivo research, including Benchling In Vivo for study design and review, in-life data capture linked to treatments and groups, multi-parameter randomization, flexible task management and scheduling, and real-time data visualization from a centralized database to save time, reduce error, and increase collaboration.
Products and services
- Real-time Data Visualization: Delivers centralized-database-backed analytics with access to current and historical study data for real-time insights into in vivo experiments
- In-life Data Capture: Captures detailed data about each animal interconnected with treatment, group, and sample-level data
- Benchling In Vivo: Architects an all-in-one in vivo platform featuring data capture, collaboration, and insights plus study design, in-life capture, multi-parameter randomization algorithms to eliminate bias, scheduling, and real-time visualization
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Overwatch Research
Aktana
HQ: United States
Website
- Description: Provider of AI-driven solutions for life science companies to optimize HCP engagement and commercial execution, including HCP Engagement AI, Next Best Action solutions, Field and Omnichannel Orchestrators, Data Readiness Assessment, and Aktana for MedTech. Supports more than 100 brands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aktana company profile →
Biomage
HQ: United Kingdom
Website
- Description: Provider of single-cell RNA-seq data analysis and visualization tools and services, including Cellenics® for no-code analysis, a comprehensive course on mastering single-cell RNA-seq with Cellenics®, and private, secure Cellenics® deployment with integration, technical support, and feature development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biomage company profile →
MedAvante-ProPhase
HQ: United States
Website
- Description: Provider of technology-enabled signal detection solutions in clinical trials of treatments for nervous system disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedAvante-ProPhase company profile →
Captario
HQ: Sweden
Website
- Description: Provider of a cloud-based SaaS platform and services for strategic decision-making in drug development. Captario SUM offers modeling and simulation to create, compare, and optimize project and portfolio pathways by value and risk, with visual project modeling and portfolio functionality. Services include portfolio management, project strategy analysis, managed portfolios, simulation-based portfolio forecasts, and quantitative disease area strategy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Captario company profile →
Q2 Metrics
HQ: Canada
Website
- Description: Provider of big-data predictive health analytics with SaaS and DaaS offerings to the healthcare industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q2 Metrics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Overwatch Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Overwatch Research
2.2 - Growth funds investing in similar companies to Overwatch Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Overwatch Research
4.2 - Public trading comparable groups for Overwatch Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →